Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

NCT04051268 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3071

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Issues
Immunogenicity

Interventions

BIOLOGICAL: Vi-DT Typhoid Conjugate Vaccine
BIOLOGICAL: PQed Typhoid Conjugate Vaccine
BIOLOGICAL: Vi Polysaccharide Vaccine

Sponsor

PT Bio Farma